Pharma Foods International Co.Ltd operates within the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Pharma Foods International Co.Ltd with three other
pharmaceutical manufacturers in Asia:
Panacea Biotec Ltd
sales of 5.86 billion Indian Rupees [US$82.07 million]
of which 69%
(2.67 billion Japanese Yen [US$24.13 million]
Hester Pharmaceuticals Limited
based in India
(1.36 billion Indian Rupees [US$19.04 million]
of which 86%
was Poultry Vaccines).
During the year ended July of 2018, sales at
Pharma Foods International Co.Ltd were ¥7.94 billion (US$71.81 million).
increase of 68.2%
versus 2017, when the company's sales were ¥4.72 billion.
This was the fifth consecutive year of sales increases at Pharma Foods International Co.Ltd
(and since 2013, sales have increased a total of 421%).
Sales of Functional Products(Online Business) saw an increase
82.9% in 2018, from
¥3.44 billion to ¥6.30 billion.
Not all segments of Pharma Foods International Co.Ltd experienced an increase in sales in 2018:
sales of Biomedical fell 15.6% to ¥36.61 million.
(However, this segment's sales were only a very small portion of the company's overall sales).